BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38112134)

  • 1. Alterations in circulating mitochondrial signals at hospital admission for COPD exacerbation.
    Amado CA; Martín-Audera P; Agüero J; Ferrer-Pargada D; Josa Laorden B; Boucle D; Berja A; Lavín BA; Guerra AR; Ghadban C; Muñoz P; García-Unzueta M
    Chron Respir Dis; 2023; 20():14799731231220058. PubMed ID: 38112134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of mitochondrial oxidative stress-related peptides MOTS-c and Romo1 in stable COPD: A cross-sectional study.
    Amado CA; Martín-Audera P; Agüero J; Lavín BA; Guerra AR; Boucle D; Ferrer-Pargada D; Berja A; Martín F; Casanova C; García-Unzueta M
    Front Med (Lausanne); 2023; 10():1100211. PubMed ID: 36844198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study.
    Amado CA; Martín-Audera P; Agüero J; Lavín BA; Guerra AR; Muñoz P; Berja A; Casanova C; García-Unzueta M
    Sci Rep; 2022 Oct; 12(1):17315. PubMed ID: 36243733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A
    Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphometric analysis of mitochondria in lymphocytes of patients with exacerbations of chronic obstructive pulmonary disease - pilot study.
    Białas AJ; Liberski PP; Zielińska A; Kumor-Kisielewska A; Szewczyk K; Miłkowska-Dymanowska J; Sitarek P; Piotrowski WJ; Górski P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2313-2318. PubMed ID: 30104871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD.
    Sala E; Villena C; Balaguer C; Ríos A; Fernández-Palomeque C; Cosío BG; García J; Noguera A; Agustí A
    Lung; 2010 Aug; 188(4):331-8. PubMed ID: 20082199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins and outcome after hospitalization for COPD exacerbation: a prospective study.
    Bartziokas K; Papaioannou AI; Minas M; Kostikas K; Banya W; Daniil ZD; Haniotou A; Gourgoulianis KI
    Pulm Pharmacol Ther; 2011 Oct; 24(5):625-31. PubMed ID: 21729761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coding of COPD Exacerbations and the Implications on Clinical Practice, Audit and Research.
    Echevarria C; Steer J; Bourke SC
    COPD; 2020 Dec; 17(6):706-710. PubMed ID: 33169617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtypes of patients experiencing exacerbations of COPD and associations with outcomes.
    Arostegui I; Esteban C; García-Gutierrez S; Bare M; Fernández-de-Larrea N; Briones E; Quintana JM;
    PLoS One; 2014; 9(6):e98580. PubMed ID: 24892936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans.
    von Walden F; Fernandez-Gonzalo R; Norrbom J; Emanuelsson EB; Figueiredo VC; Gidlund EK; Norrbrand L; Liu C; Sandström P; Hansson B; Wan J; Cohen P; Alkner B
    J Appl Physiol (1985); 2021 Sep; 131(3):1035-1042. PubMed ID: 34351816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Low-Dose versus High-Dose Continuous Cyclic Azithromycin Therapy for Preventing Acute Exacerbations of COPD.
    Pomares X; Montón C; Huertas D; Marín A; Cuevas E; Casabella A; Martí S; Oliva JC; Santos S
    Respiration; 2021; 100(11):1070-1077. PubMed ID: 34365450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balance and Falls in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Prospective Study.
    Oliveira CC; Lee AL; McGinley J; Anderson GP; Clark RA; Thompson M; Clarke S; Baker T; Irving LB; Denehy L
    COPD; 2017 Oct; 14(5):518-525. PubMed ID: 28745525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonia as comorbidity in chronic obstructive pulmonary disease (COPD). Differences between acute exacerbation of COPD and pneumonia in patients with COPD.
    Boixeda R; Bacca S; Elias L; Capdevila JA; Vilà X; Mauri M; Almirall J
    Arch Bronconeumol; 2014 Dec; 50(12):514-20. PubMed ID: 25443591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte distribution width (MDW) and DECAF: two simple tools to determine the prognosis of severe COPD exacerbation.
    Amado CA; Ghadban C; Manrique A; Osorio JS; Ruiz de Infante M; Perea R; Gónzalez-Ramos L; García-Martín S; Huidobro L; Zuazaga J; Druet P; Argos P; Poo C; Muruzábal MJ; España H; Andretta G
    Intern Emerg Med; 2024 May; ():. PubMed ID: 38722501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of integrated pulmonary index to predict exacerbation of chronic obstructive pulmonary Disease's severity.
    Karaarslan FN; Öztürk ZS; Işık GÇ; Çevik Y
    Am J Emerg Med; 2023 Sep; 71():54-58. PubMed ID: 37331230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation.
    Quintana JM; Esteban C; Garcia-Gutierrez S; Aguirre U; Gonzalez N; Lafuente I; Bare M; Fernandez de Larrea N; Rivas-Ruiz F;
    Respiration; 2014; 88(4):298-306. PubMed ID: 25228470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the Rome classification of chronic obstructive pulmonary disease exacerbation severity be applied in the hospital setting?
    Cometa M; Ursitti A; Lombardo LP; Rana R; Gardani A; Contoli M; Papi A
    Respir Med; 2024 Feb; 222():107509. PubMed ID: 38145723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between P-pulmonale and respiratory morbidity in COPD: a secondary analysis of the BLOCK-COPD trial.
    Wade RC; Mkorombindo T; Ling SX; Helgeson ES; MacDonald DM; Pew K; Voelker H; Bittner V; Kunisaki KM; Lammi MR; Dransfield MT
    BMC Pulm Med; 2023 Nov; 23(1):434. PubMed ID: 37946165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD.
    Minas M; Mystridou P; Georgoulias P; Pournaras S; Kostikas K; Gourgoulianis KI
    COPD; 2013 Feb; 10(1):28-34. PubMed ID: 23272665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-level differential network analysis of COPD exacerbations.
    Noell G; Cosío BG; Faner R; Monsó E; Peces-Barba G; de Diego A; Esteban C; Gea J; Rodriguez-Roisin R; Garcia-Nuñez M; Pozo-Rodriguez F; Kalko SG; Agustí A
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28954781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.